James M. Frates, CFO: Amylyx Pharmaceuticals AMLX Planned sale · Filed 09/11

Trade details

Type: Planned sale notice
Stock: Amylyx Pharmaceuticals AMLX
Person: James M. FratesCFO
Planned sale date: 26/09/10
Filed: 26/09/11

4.6% of shares outstanding to be sold

Amylyx Pharmaceuticals trades, last 26 weeks

What else happened in Amylyx Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 08/11~10/10

James M. Frates's recent trades

James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$114.8K
7,909 sh
$114.8K
Filed 03/04
Traded 03/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$114.9K
7,909 sh
$114.9K
Filed 03/02
Traded 03/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/04
Traded 02/02
James M. FratesCFO
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$52.1K
3,557 sh
$52.1K
Filed 02/02
Traded 02/02
James M. FratesCFO
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$37K
3,326 sh
$37K
Filed 01/08
Traded 01/06

James M. Frates, CFO — plans to sell 10,810 sh of Amylyx Pharmaceuticals AMLX · $349.8K · around 09/10 | Whalegun